Literature DB >> 10513819

Mixed cryoglobulinemia secondary to visceral Leishmaniasis.

M Casato1, F G de Rosa, L P Pucillo, I Ilardi, B di Vico, L R Zorzin, M L Sorgi, P Fiaschetti, R Coviello, B Laganà, M Fiorilli.   

Abstract

We describe a case of type II mixed cryoglobulinemia, with monoclonal IgMkappa rheumatoid factor, associated with visceral leishmaniasis caused by Leishmania infantum. Involvement of Leishmania antigen(s) in the formation of cryoprecipitable immune complexes was suggested by the fact that cryoglobulinemic vasculitis subsided after antiparasite therapy and that anti-Leishmania antibodies, as well as rheumatoid factor, were enriched in the cryoprecipitate. We observed 2 additional patients with visceral leishmaniasis and cryoglobulinemic vasculitis. All 3 patients had seemingly contracted leishmaniasis in Italy, were hepatitis C virus negative, and were initially diagnosed as having autoimmune disorders. These findings indicate that Leishmania can be an etiologic agent of type II mixed cryoglobulinemia. This parasitosis should be taken into consideration in the differential diagnosis of vasculitides in endemic areas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10513819     DOI: 10.1002/1529-0131(199909)42:9<2007::AID-ANR30>3.0.CO;2-X

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

1.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

3.  Cryoglobulinemic purpura in visceral leishmaniasis.

Authors:  Evangelos Rizos; George Dimos; Evangelos N Liberopoulos; Moses S Elisaf; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2004-11-10       Impact factor: 2.631

4.  Visceral leishmaniasis: A case report.

Authors:  Sachin Gawade; Mangesh Nanaware; Rm Gokhale; Ps Adhav
Journal:  Australas Med J       Date:  2012-02-29

5.  Visceral leishmaniasis resembling systemic lupus erythematosus.

Authors:  Michalis Voulgarelis; Paraskevi V Voulgari; John Serelis; Alexandros A Drosos; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2003-10-31       Impact factor: 2.980

6.  Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap.

Authors:  Ozlem Guzel Tunccan; Abdurrahman Tufan; Gülçin Telli; Nalan Akyürek; Merve Pamukçuoğlu; Güldal Yılmaz; Kenan Hızel
Journal:  Korean J Parasitol       Date:  2012-05-24       Impact factor: 1.341

7.  Retinal changes in visceral leishmaniasis by retinal photography.

Authors:  Richard James Maude; B U M Wahid Ahmed; Abu Hayat Md Waliur Rahman; Ridwanur Rahman; Mohammed Ishaque Majumder; Darryl Braganza Menezes; Abdullah Abu Sayeed; Laura Hughes; Thomas J MacGillivray; Shyamanga Borooah; Baljean Dhillon; Arjen M Dondorp; Mohammad Abul Faiz
Journal:  BMC Infect Dis       Date:  2014-09-30       Impact factor: 3.090

8.  Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype.

Authors:  Guadalupe Andreani; Michel Ouellet; Rym Menasria; Alejandro Martin Gomez; Corinne Barat; Michel J Tremblay
Journal:  PLoS Negl Trop Dis       Date:  2015-02-24

9.  Rare Association of Leukocytoclastic Vasculitis in Visceral Leishmaniaisis.

Authors:  Bharath A Chhabria; Ram V Nampoothiri; Sweta Rajpal; Kirti Gupta; Sanjay Jain
Journal:  Oman Med J       Date:  2019-01

10.  Membranoproliferative Glomerulonephritis and Mixed Cryoglobulinemia as a Form of Presentation of Visceral Leishmaniasis.

Authors:  Maite Padrón Romero; Mercedes M Acevedo Ribó; Francisco Javier Ahijado Hormigos; Francisco Díaz Crespo; Laura Cueto Bravo; Cristina Herraiz Corredor; María Ángeles Fernández Rojo; Rafael Díaz-Tejeiro Izquierdo
Journal:  Am J Case Rep       Date:  2020-05-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.